California First to Sign Voluntary Agreement, Pay HISA 2023 Fees

The Golden State is the first jurisdiction in the country to sign a voluntary agreement with the Horseracing Integrity & Welfare Unit (HIWU) to continue performing a host of vital roles when the Horseracing Integrity and Safety Act's (HISA) drug control program goes into effect Mar. 27, according to a statement Friday by the California Horse Racing Board (CHRB).

In another first among the nation's racing jurisdictions, the CHRB also agrees to pay HISA's 2023 fee assessment. The total figure for the state is more than $6.7 million. However, after HISA's credits have been applied, the final amount that California owes HISA comes out to roughly $1.5 million, according to the voluntary agreement.

“The CHRB has been enforcing and complying with safety regulations that HISA introduced July 1, 2022. Under the new agreement, the CHRB will implement rules under the Anti-Doping and Medication Control (ADMC) Program, which are scheduled to go into effect March 27, 2023,” the CHRB's Friday statement read.

Under the voluntary agreement–shared by CHRB executive director Scott Chaney with TDN–the CHRB agrees to continue performing certain tasks for the HISA Authority and for HIWU, including the collection of equine samples, and the testing of these samples at the University of California, Davis's Kenneth L. Maddy Equine Analytical Laboratory.

In turn, U.C. Davis's “Maddy Lab” also becomes the first laboratory to officially sign onto HIWU's drug testing program.

Because state racing commissions and their respective industries already pay for many of HIWU's anti-doping and medication control program components, HISA is offering credits as subsidies to its annual fees.

According to California's voluntary agreement, the commission's total “state testing credit” will be $4.7 million. This includes some $1.2 million for sample collection and $3.5 million for laboratory costs such as race-day testing, research, and the analysis of samples from other states.

California also receives an additional out-of-competition testing credit estimated to be around $450,000 annually.

“If the costs for out-of-competition testing outside of Race Day pursuant to this Paragraph exceed $450,000 at the end of 2023, the Commission will receive an additional credit for 2024 in the amount of the excess costs,” the voluntary agreement reads.

“The CHRB is proud of our work and record in safety and animal welfare, and therefore we want to have a role in shaping policy going forward,” said Chaney in the statement issued Friday. “We have partnered and supported the national effort from the beginning and appreciate the dedication of the Authority and HIWU.”

The CHRB's statement adds: “The CHRB and representatives of the Del Mar Thoroughbred Club, 1st Racing, the Thoroughbred Owners of California, and UC Davis have been advising HISA all along, promoting California's strict regulatory program, and partly for that reason the federal rules are similar to those in California, meaning participants in California horse racing will need to make fewer adjustments than some of their counterparts in other racing jurisdictions.”

The post California First to Sign Voluntary Agreement, Pay HISA 2023 Fees appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

At 1-Month Mark For Drug Control, HISA Braces Industry For Changes

Four weeks out from the anticipated effective date for the Anti-Doping and Medication Control Program (ADMC), the Authority overseeing the Horseracing Integrity and Safety Act (HISA) is stepping up its awareness campaign so industry participants can be properly prepared for a sweeping change in regulatory protocols.

“We are officially on the one-month countdown to what we are confident will be the launch of our ADMC program on Mar. 27,” Lisa Lazarus, the chief executive officer for the HISA Authority, said during a Monday video press conference.

“Everyone is sort of on the same page of wanting uniformity and wanting consistency,” Lazarus continued. “And we're excited for the chance to actually show the industry what that looks like. I think once we get past Mar. 27, we'll be able to convert some doubters into believers.”

Part of what Lazarus and Ben Mosier, the executive director for the Horseracing Integrity and Welfare Unit (HIWU), are trying to get across to industry entities is that the looming ADMC implementation date is a very real deadline that they believe will not be affected by any current court action.

Mosier underscored that the ADMC launch is “what my team is focused on right now until somebody tells us otherwise.”

Added Lazarus: “One of the challenges for us, and why we are beating the drum as much as we possibly can, is to make sure stakeholders realize this is actually coming on Mar. 27. The moment the Federal Trade Commission [FTC] approves the [ADMC] regulations, they are effective.”

That date represents the last day of the FTC's  60-day review period for the ADMC rules, and Lazarus said “all indications” are that the FTC will greenlight them.

“The minute they approve them, state racing commissions are out of the drug-testing business, and we're the sole entity responsible in those states where HISA is operating,” Lazarus said.

Lazarus did note an exception: “The [federal] court in Louisiana has enjoined HISA from operating in Louisiana and West Virginia, so we will not be administering the ADMC program in those states, and yes, state regulations will continue to be in effect there.”

Lazarus also noted that the four federal lawsuits aiming to try to derail HISA were all initiated prior to the December 2022 rewrite of the HISA law that amended the act's operational language with the aim of quelling legal allegations of anti-constitutionality.

“I really don't think there is anything” in the courts that can stop the FTC's approval from happening, “which is why I'm so confident,” Lazarus said. “There is no pending legal action that is on the schedule to be resolved ahead of Mar. 27, [and] no party, no person, no entity has mounted any challenge to that [rewritten] law.”

Asked about immediate changes that horse owners and trainers might notice on Day 1 of implementation, Mosier noted several examples. One involved exactly who-HISA personnel or the existing track stewards-would be responsible for selecting horses for post-race testing.

“All testing is managed and directed by HIWU,” Mosier explained. “But what we're doing, and don't want to lose, is the ability for local personnel to inform testing selections. And what I mean by that is currently [in] the industry, the stewards [select horses for post-testing]. And we're not going to lose that ability. But we have to ensure that their selections are done in compliance with the rules, so we're working very closely with the stewards to make sure that they are educated and understand the rules and are essentially certified to now do this under our direction.”

Mosier continued: “We can also still hear information actively from veterinarians, or other personnel, on the ground [regarding factors] they see on the backstretch that typically flow up to the stewards on a daily basis.”

But, Mosier added, the flow of “nationwide intelligence” will also work in the other direction, meaning that local testing protocols might be triggered by information that flows downward from higher-up Authority entities, including from tips that come via HISA's whistleblower program.

Lazarus put it this way: “I think having a nationwide strategy that is intelligence-driven is going to be an opportunity for the industry to see how clean [or not]” the sport is.

Lazarus added that participants will experience “far higher levels of out-of-competition testing that the industry's ever seen, [instead of] almost-exclusive reliance on post-race testing to manage integrity.”

Mosier said when a horse is brought to a test barn, for example, the chain of custody will be paperless.

Mosier said horsemen can expect to have to electronically sign off on testing via an iPad (with instructions available in both English and Spanish), and that this system will assign unique markers that will accompany the specimen samples to the testing lab. Horsemen will then be electronically forwarded receipts from the test-barn process to streamline and provide proof of testing.

The post At 1-Month Mark For Drug Control, HISA Braces Industry For Changes appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

HIWU Appoints Three to Executive Team

The Horseracing Integrity & Welfare Unit (HIWU) announced three appointments to its executive leadership team-Ben Mosier to the role of Executive Director, Kate Mittelstadt to Chief of Operations, and Michelle Pujals to General Counsel. Both Mittelstadt and Pujals will report to Mosier.

The Horseracing Integrity and Safety Authority (HISA), in consultation with HIWU, is preparing to submit draft regulations for the Anti-Doping and Medication Control (ADMC) Program to the U.S. Federal Trade Commission for review ahead of implementation of the Program Jan. 1, 2023.

Mosier joined Drug Free Sport International (DFSI), the independent enforcement agency selected by HISA to operate HIWU and administer the ADMC Program, in 2010. He most recently served as Vice President of Business Development at DFSI and has overseen anti-doping programs for the National Basketball Association (NBA), the PGA Tour, Major League Baseball's Minor League Program, and NASCAR. Prior to joining DFSI, Mosier served as National Events Coordinator at the Kansas City Sports Commission.

Mittelstadt most recently served as Director of the IRONMAN Anti-Doping Program, which became the first program run by a private, non-federation sports organization that formally adhered to the World Anti-Doping Code. Mittelstadt's career in anti-doping began in 2000, when she became one of the first employees hired by the U.S. Anti-Doping Agency, and where she served for six years as Director of Doping Control. During that time, she was manager of Out-of-Competition Testing at the 2002 Winter Olympic Games in Salt Lake City. She has since served in various capacities with the World Anti-Doping Agency and the Association of National Anti-Doping Organizations.

Pujals, who served for over 20 years as a member of the NBA's legal department, most recently as Vice President & Assistant General Counsel. During her tenure, she oversaw the development and administration of anti-drug programs for NBA players, coaches, and trainers, and was a member of the NBA/NBPA Prohibited Substances Committee and the NBA Crisis Management Team. Pujals also oversaw the NBA's general litigation matters, internal arbitrations and investigations, and the development of the NBA Arena Security Standards. Prior to joining HIWU, she was the owner and principal of Tautemo Consulting, LLC, a legal and sports consulting firm.

The post HIWU Appoints Three to Executive Team appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Lazarus on HISA Anti-Doping and Medication Control

Bit by bit, the pieces of the puzzle are slotting into place for the Anti-Doping and Medication Control (ADMC) component of the Horseracing Integrity and Safety Act, set to go into effect at the start of next year.

Last month, that program was designated an agency to officially run it–namely Drug Free Sports International, an organization that has helped administer drug testing programs to a slew of major human sports leagues.

Then, last week, the draft ADMC rules were for put out public comment. These draft rules can be found here.

Adolpho Birch, Chair of HISA's ADMC Committee, concurrently issued a letter outlining the primary changes to the revised ADMC rules as compared to the draft rules previously issued, when the United States Anti-Doping Agency's (USADA) appeared set to become HISA's enforcement agency.

In the letter, Birch points out that possible sanctions for controlled therapeutic medication violations have been reduced, to make a clearer distinction between medication offenses where banned substances are administered, and those when controlled therapeutic substances have been given.

Furthermore, in the event of a positive test result and a request for a B sample analysis, someone from the enforcement agency itself will choose the laboratory, which may be a different laboratory from the one that did the initial analysis.

Tuesday morning, HISA CEO Lisa Lazarus held a media Q&A to discuss the draft ADMC rules further. The following is a summary of her comments.

Responsible Persons

Lazarus provided interesting context to the reasons underpinning the need for trainers and owners to maintain daily treatment records for the horses in their care, a basic outline for which can be found here.

The registration system designates a responsible person for each horse. And that in turn places the burden on the responsible trainer or owner to make sure that they keep detailed records and documentation–essentially, run a “tight ship,” as Lazarus put it.

In the event of a medication violation, therefore, the HISA Authority can request these documents and records, “and those records can become part of the case,” said Lazarus.

In relation to this, Lazarus also expanded on HISA's “whereabouts” program, which essentially ensures that all horses under HISA's remit are accounted for at all times.

In the first phase of the whereabouts program, set to go into effect early next year, responsible persons are required to submit a whereabouts filing if they remove a horse from a racetrack or registered facility.

In other words, said Lazarus, “If you take a horse to a private facility or a private farm, you have to notify us.” And there are possible penalties for non-compliance, including potential fines for failure to submit a whereabouts filing.

However, failure to produce a horse for drug testing results in a presumptive two-year violation (pending a hearing), irrespective of any test result.

“If you take a horse off a public racetrack where we know where the horse is, you don't tell us where the horse is with the whereabouts filing, we look for the horse, we reach out to the Covered Person–we're going to have access to all of this through our database–and they don't produce [the horse] immediately for testing, then, it's a presumptive two-year penalty,” said Lazarus.

Ultimately, said Lazarus, the plan is for a system in place that identifies the whereabouts of any covered horse at any time.

“But one of the things we want to understand and see is whether or not we can really just mine that data from existing resources without putting a paperwork burden on participants,” she said.

Case Management

Before diving into this section, there are some important nomenclature changes to note, as compared to the previous draft rules' use of “primary” and “secondary” substances.

Under these revised draft rules, “prohibited substances” is an umbrella term for anything that shouldn't be in a horse on race day. Banned substances refers to doping substances, while controlled medications are essentially therapeutic substances.

A list of banned and controlled substances, along with possible sanctions in the event of a positive test result, can be found here.

Lazarus provided a snap-shot of the case management process.

In the event a horse tests positive for a banned substance like a steroid, an anabolic agent or a growth hormone, the responsible person is immediately suspended until a hearing takes place.

“The presumption is that this is a two-year sanction,” said Lazarus.

However, that two-year sanction can be reduced if the responsible person can show “no fault or no significant fault,” said Lazarus, adding how any penalty reduction is predicated upon the responsible person proving how the substance got into the horse's system in the first place.

“So, for example, if you're in a situation of a steroid [positive] and you want to argue that somebody gave the horse a steroid without your knowledge, you have to actually prove that [scenario] to the confidence and satisfaction of the hearing panel,” said Lazarus, who also explained how there will be potential four-year bans in the event of “aggravating circumstances” like trafficking, evading sample collection and tampering with samples.

Public Disclosure of Test Results

Under USADA's version of the ADMC program, one rather controversial component concerned how A samples results weren't necessarily going to be automatically disclosed to the public.

But Lazarus pointed to a change of tune, with A sample results now indeed set to be made available online.

“You'll know the covered person, covered horse, and the substance that was detected in the sample,” she said. “You'll be able to follow the case essentially as it goes through the various steps. [For example,] if there's a hearing to lift a suspension that'll be recorded, the decision will be recorded,” she added.

Shortened Adjudication Timelines

The timeline to hear and adjudicate cases will be “incredibly reduced” when compared to the current model at the individual state level, said Lazarus.

After a hearing, for example, the arbitrator will have to issue a decision within 14 days. In the appeals process, defendants have 30 days to file an appeal to the charges, and then, a hearing must happen within 60 days after initial notice.

When asked if the tightened system provides adequate time for defendants to mount a fair defense–especially in complex cases–Lazarus said that cases will be adjudicated on an individual basis, with wriggle room given in “exceptional circumstances” so as not to compromise due process.

That said, the truncated timeline–along with any provisional suspension in the event of a banned substance violation–could also act as an incentivizing lever, said Lazarus.

“If you're dealing with a two-year penalty and it's a banned substance, you're going to be suspended during the case processing scheduling period, and so they're probably going to be very motivated to have it heard quickly as well, so, it also protects the participants,” she said.

Registration Numbers

According to Lazarus, nearly half the horses and covered persons who need to be registered by July 1 have done so. However, racing offices will soon provide a “can't race flag” if a horse that is entered to race is not registered with HISA, she said.

This is intended more as a prompt, said Lazarus, as it won't necessarily affect the horse's eligibility to race, just as long as that horse is, indeed, registered by July 1.

Drug Testing

The actual ADMC testing program is still being developed, said Lazarus, and so, specifics are thin.

That said, in the past various officials have suggested that under HISA, all winners won't necessarily be tested post-race–something of a departure from the current model.

Lazarus indicated, however, that indeed, the post-race drug testing net could still accommodate all winners.

“We're trying to balance a robust testing program that has a deterrent effect with the intelligence-based advantages you get from looking at intelligence metrics,” said Lazarus.

The post Lazarus on HISA Anti-Doping and Medication Control appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights